当前位置:首页 - 行情中心 - 海尔生物(688139) - 财务分析

海尔生物

(688139)

  

流通市值:98.25亿  总市值:98.25亿
流通股本:3.18亿   总股本:3.18亿

海尔生物(688139)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.16亿元,每股收益0.35元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益470880.13万元,未分配利润217043.57万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产583044.06万元,负债112163.93万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入688,989,400.72,283,832,911.431,782,020,224.831,223,284,970.75
营业总成本575,353,290.721,941,857,521.471,468,536,204.53979,179,228.79
营业利润126,546,211.91401,827,808.74340,804,804.26256,790,390.69
利润总额125,489,878.45401,956,704.73342,418,496.53258,868,887.07
净利润116,197,969.19381,008,045.8318,977,945.89239,137,127.93
其他综合收益457,278.77-13,065,819.88-23,664,262.3-24,452,127.42
综合收益总额116,655,247.96367,942,225.92295,313,683.59214,685,000.51
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,863,421,109.962,652,447,941.352,660,812,428.82,405,604,989.66
非流动资产合计2,967,019,491.483,135,020,853.662,980,882,308.023,181,116,685.13
资产总计5,830,440,601.445,787,468,795.015,641,694,736.825,586,721,674.79
流动负债合计966,907,036.971,022,403,542.51948,841,682.54936,632,024.16
非流动负债合计154,732,287.72146,929,219.71151,377,325.7152,522,625.35
负债合计1,121,639,324.691,169,332,762.221,100,219,008.241,089,154,649.51
归属于母公司股东权益合计4,456,255,374.14,371,550,511.014,301,632,773.154,254,327,364.48
股东权益合计4,708,801,276.754,618,136,032.794,541,475,728.584,497,567,025.28
负债和股东权益合计5,830,440,601.445,787,468,795.015,641,694,736.825,586,721,674.79
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计580,704,504.072,429,286,249.011,654,629,831.451,088,512,990.31
经营活动现金流出小计543,485,302.532,137,619,330.751,540,662,380.111,029,236,956.55
经营活动产生的现金流量净额37,219,201.54291,666,918.26113,967,451.3459,276,033.76
投资活动现金流入小计1,109,537,955.232,981,647,918.692,056,540,467.271,296,735,713.19
投资活动现金流出小计1,027,103,424.733,772,864,625.612,511,099,207.531,294,636,967.71
投资活动产生的现金流量净额82,434,530.5-791,216,706.92-454,558,740.262,098,745.48
筹资活动现金流入小计194,362,611.12193,985,922.810,550,00010,250,000
筹资活动现金流出小计212,531,263.4420,813,197.24230,530,706.38202,206,159.43
筹资活动产生的现金流量净额-18,168,652.28-226,827,274.44-219,980,706.38-191,956,159.43
汇率变动对现金及现金等价物的影响1,204,511.814,434,529.58962,777.382,036,804.43
现金及现金等价物净增加额102,689,591.57-721,942,533.52-559,609,217.92-128,544,575.76
期末现金及现金等价物余额637,393,622.25534,704,030.68697,037,346.281,128,101,988.44
最新报告期:2025-05-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华创证券郑辰,李婵娟1.391.712.022025-05-06
兴业证券东楠,孙媛媛,黄翰漾1.381.681.972025-04-18
中信证券宋硕,陈竹,曾令鹏1.381.651.962025-04-15
华创证券郑辰,李婵娟1.391.712.022025-04-09
东海证券伍可心,杜永宏1.281.521.772025-04-08
TOP↑